Gyre Therapeutics GYRE
NASDAQ GYRE
$4.23 -0.42 (-9.03%)
At close: Nov 10, 2026 · 4:00 PM EST

Gyre Therapeutics (GYRE) Restructuring Costs (2012 - 2026)

Updated

Gyre Therapeutics' Restructuring Costs was $874,000 in Q2 2015, down 24.4% from the prior quarter.

Analysis

Gyre Therapeutics (GYRE) Restructuring Costs (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Gyre Therapeutics' Restructuring Costs was $3.75 million through Jun 30, 2015; for FY2014, it was $318,000, up 3.9% from FY2013.

  • In earlier years, Restructuring Costs was $306,000 in FY2013 (-91.8%) and $3.72 million in FY2012.
  • Quarterly Restructuring Costs has moved between $318,000 (Q4 2014) and $2.31 million (Q2 2012) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Gyre Therapeutics 487.81 Mn 295.13 Mn 30.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 50,000.00
Jun 30, 2026 502,000.00
Mar 31, 2026 2.55 Mn
Jun 30, 2015 874,000.00
Mar 31, 2015 1.16 Mn
Dec 31, 2014 318,000.00
Dec 31, 2012 1.41 Mn
Jun 30, 2012 2.31 Mn
API Access

Gyre Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=GYRE&period=max&api_key=YOUR_API_KEY